- The 1st Indonesian Society Gynecologic Oncology Scientific Meeting (INASMEET), November 12th to November 13th, 2022
-
Anggraeni TD, Tjokroprawiro BA
- KMID: 2552493
- J Gynecol Oncol.
- 2023 Jan;34(1):e26.
- doi: 10.3802/jgo.2023.34.e26
-
- CITED
-
- Close
- SHARE
-
- Close
- Reviewer recognition in 2022
-
- KMID: 2552495
- J Gynecol Oncol.
- 2023 Jan;34(1):e30.
- doi: 10.3802/jgo.2023.34.e30
-
- CITED
-
- Close
- SHARE
-
- Close
- Asian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic
-
Kobayashi Y, Komatsu H, Isobe M, Meena J, Weng CS, Kim SI, Wong JJ, Kwok ST, Yang J, Mathaveechotikul P, Yee KLC, Kim JW, Ushijima K
- KMID: 2552492
- J Gynecol Oncol.
- 2023 Jan;34(1):e22.
- doi: 10.3802/jgo.2023.34.e22
-
- CITED
-
- Close
- SHARE
-
- Close
- Lessons learned with a longer follow-up from SOLO 1
-
Paulino E
- KMID: 2552494
- J Gynecol Oncol.
- 2023 Jan;34(1):e29.
- doi: 10.3802/jgo.2023.34.e29
-
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ
-
Liu J, Wang Y, Wan X, Zou J, Zhu Y, Lv W, Shen Y
- KMID: 2552483
- J Gynecol Oncol.
- 2023 Jan;34(1):e8.
- doi: 10.3802/jgo.2023.34.e8
Objective To compare the safety between cervical conization (CC) alone and hysterectomy for patients with adenocarcinoma in situ (AIS) of the cervix. Methods Patients diagnosed with AIS after CC during 2007–2021 were identified... -
- CITED
-
- Close
- SHARE
-
- Close
- Perceptions and practice patterns of cancer survivorship care among Japanese gynecologic oncologists: The JGOG questionnaire survey
-
Asai-Sato M, Suzuki N, Sakai H, Itani Y, Sato S, Futagami M, Yoshida Y
- KMID: 2552488
- J Gynecol Oncol.
- 2023 Jan;34(1):e10.
- doi: 10.3802/jgo.2023.34.e10
Objective This study aimed to assess gynecologic oncologists (GOs)’ perceptions and attitudes toward cancer survivorship to help improve survivor care. Methods We conducted a web-based questionnaire survey about survivorship issues for the GOs... -
- CITED
-
- Close
- SHARE
-
- Close
- Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review
-
Fusegi A, Kanao H, Tsumura S, Murakami A, Abe A, Aoki Y, Nomura H
- KMID: 2552491
- J Gynecol Oncol.
- 2023 Jan;34(1):e5.
- doi: 10.3802/jgo.2023.34.e5
Radical hysterectomy is a standard surgery to treat early-stage uterine cervical cancer. The Laparoscopic Approach to Cervical Cancer (LACC) trial has shown that patients receiving minimally invasive radical hysterectomy have... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study
-
Seino M, Nagase S, Ohta T, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, Kaneuchi M, Enomoto T, Mikami M
- KMID: 2552482
- J Gynecol Oncol.
- 2023 Jan;34(1):e4.
- doi: 10.3802/jgo.2023.34.e4
Objective The aim of this study was to review the clinicopathological characteristics of small cell neuroendocrine cervical cancer (SCNEC) and to identify the optimal treatment. Methods The Japanese Society of Gynecologic Oncology conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
-
Kim SI, Kim JH, Lee C, Ha J, Jung KW, Lim MC
- KMID: 2552487
- J Gynecol Oncol.
- 2023 Jan;34(1):e9.
- doi: 10.3802/jgo.2023.34.e9
Objective To investigate the incidence and survival rates of primary uterine carcinosarcoma (UCS) in Korea. Methods From the Korea Central Cancer Registry, we identified patients diagnosed with primary UCS between 1999 and 2018... -
- CITED
-
- Close
- SHARE
-
- Close
- Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic
-
Carpini GD, Rossi PG, Giannella L, Giuseppe JD, Clemente N, Sopracordevole F, Barbero M, Bogani G, Vincenzo RD, Origoni M, Cantatore F, Gardella B, Dominoni M, Monti E, Liverani CA, Viscardi A, Pagan A, Amadori A, Alessi C, Andolfatto M, Cattani P, Pieralli A, Stevenazzi G, Ciavattini A
- KMID: 2552486
- J Gynecol Oncol.
- 2023 Jan;34(1):e7.
- doi: 10.3802/jgo.2023.34.e7
Objective To evaluate the impact of healthcare reorganization during the severe acute respiratory syndrome coronavirus 2 pandemic on Italian colposcopy clinic activities, focusing on cervical excision procedures, follow-ups for conservative management... -
- CITED
-
- Close
- SHARE
-
- Close
- Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis
-
Sakamoto I, Hirotsu Y, Amemiya K, Nozaki T, Mochizuki H, Omata M
- KMID: 2552485
- J Gynecol Oncol.
- 2023 Jan;34(1):e6.
- doi: 10.3802/jgo.2023.34.e6
Objective Elucidation of clonal origin of synchronous endometrial and ovarian cancers (SEOs). Methods We reviewed 852 patients who diagnosed endometrial and/or ovarian cancer. Forty-five (5.3%) patients were diagnosed as SEOs. We evaluated blood... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix
-
Kuji S, Endo A, Kubota M, Uekawa A, Kawakami F, Mikami Y, Koike J, Suzuki N
- KMID: 2552480
- J Gynecol Oncol.
- 2023 Jan;34(1):e1.
- doi: 10.3802/jgo.2023.34.e1
Objective Previously, we reported that insulinoma-associated protein 1 (INSM1) immunohistochemistry (IHC) showed high sensitivity for neuroendocrine carcinoma of the uterine cervix and was an effective method for histopathological diagnosis, but that... -
- CITED
-
- Close
- SHARE
-
- Close
- Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity
-
Nian Y, Li X, Ma J, Gao T, Liu D
- KMID: 2552489
- J Gynecol Oncol.
- 2023 Jan;34(1):e11.
- doi: 10.3802/jgo.2023.34.e11
Background Endometrial carcinoma (EC) is one of the most common malignant tumors of the female reproductive tract, involving multiple molecular alterations. Circular RNA (circRNA) dysregulation is frequently observed in EC tissues,... -
- CITED
-
- Close
- SHARE
-
- Close
- Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan
-
Chou HH, Fereday S, DeFazio A, Chang CL, Bowtell D, Hsu HC, Traficante N, Jeong SY, Cheng WF, Ariyarantne D, Australian Ovarian Cancer Study Group, Tung T, Rajadhyaksha V, Lee WH, Brown D, Kim BG
- KMID: 2552484
- J Gynecol Oncol.
- 2023 Jan;34(1):e3.
- doi: 10.3802/jgo.2023.34.e3
Objective The real-world INFORM study analyzed sociodemographics, treatment patterns and clinical outcomes for patients with newly diagnosed advanced epithelial ovarian cancer (EOC) in Australia, South Korea (S.Korea) and Taiwan preceding incorporation... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of CD4+ cells infiltration as a prognostic factor in cervical intraepithelial neoplasia 2
-
Chen G, Iwata T, Sugawara M, Nishio H, Katoh Y, Kukimoto I, Aoki D
- KMID: 2552481
- J Gynecol Oncol.
- 2023 Jan;34(1):e2.
- doi: 10.3802/jgo.2023.34.e2
Objective To identify candidate predictors for the prognosis of cervical intraepithelial neoplasia 2 (CIN2) lesions and evaluate the prognostic value of the local immune response. Methods One hundred fifteen CIN2 patients were enrolled.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914)
-
Xu Z, Yang B, Guan J, Shan W, Liao J, Shao W, Chen X
- KMID: 2552490
- J Gynecol Oncol.
- 2023 Jan;34(1):e32.
- doi: 10.3802/jgo.2023.34.e32
Objective To evaluate the effect of levonorgestrel-releasing intrauterine system (LNG-IUS) plus oral megestrol acetate (MA) as fertility-preserving treatment in patients with early-stage endometrial cancer (EEC). Methods In this single-center, phase II study with... -
- CITED
-
- Close
- SHARE
-
- Close
